Perspective
Our work in Perspective
-
How the Next President Should Reform Medicare
If left alone, Medicare Advantage will increasingly push overall costs in Medicare into unsustainable territory. Needed reforms can be phased in over a period of years.
Categorized in -
Congress Must Roll Back a Key Anti-Innovation Biden-Harris Policy
Improving FDA efficiency and eliminating CMS barriers to coverage will help get life-saving treatments to patients more quickly.
Categorized in -
Got an Unaffordable or Incorrect Medical Bill? Calling Your Hospital Billing Office Will Usually Get You a Discount
Advocating for yourself can pay off when it comes to medical bills, and you may be missing out on financial relief when you don’t pick up the phone.
Categorized in -
If You Want Americans to Pay Attention to Climate Change, Just Call It Climate Change
Phrases like ‘climate crisis,’ ‘climate emergency’ or ‘climate justice’ might seem to escalate the urgency, but a large survey shows they don’t help and may actually hurt.
Categorized in -
Responding to Some ‘Inconvenient’ Truths About PBMs
The lack of transparency and inability of plan sponsors to assess how much pharmacy benefit managers generate in savings and how much they retain for themselves is the root issue.
Categorized in -
Comments to Representatives DeGette and Bucshon on Building on the Successes of 21st Century Cures
Schaeffer Center experts provided comments to lawmakers on additional measures for enhancing or improving the effectiveness of the 21st Century Cures Act.
Categorized in -
State Mandates to Cap Out-of-Pocket Insulin Costs Are No Longer Necessary
State laws capping patients’ out-of-pocket insulin costs, though well-intentioned, have had limited impact.
Categorized in -
A Patient-Focused, Evidence-Driven Approach to PBM Reform
As policymakers consider reforms to the prescription drug supply chain, they should keep five principles in mind to ensure better outcomes for patients.
Categorized in -
Comments to CMS on Transcatheter Tricuspid Valve Replacement (TTVR) and Broader CED Policy Considerations
Schaeffer Center experts provided comments to CMS on issues with how Coverage with Evidence Determination policy is applied.
Categorized in -
Estimating Overpayments to MA Plans: MedPAC Critics Get It Wrong
Why many of the key assertions in a recent Forefront article challenging the MedPAC’s estimate that favorable selection and upcoding increase payments to Medicare Advantage (MA) plans in 2024 by $83 billion are wrong.
Categorized in